UV–Vis spectroscopic quantification of residual acetone during the development of nanoparticulate drug delivery systems

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Methods for nanoparticles preparation often employ organic solvents in order to solubilize the non-polar constituents of the final nanostructures. In the research process, nanoparticles are assayed as aqueous suspensions in several cases, so that an excessive residual concentration of the organic solvent needs to be avoided since may lead to undesired secondary effects during biological tests. Despite the importance, residual solvent concentration is rarely determined, making necessary the development of quantification methods suitable for this purpose. Acetone is frequently used in drug delivery systems preparation, being capable to exert significant toxicities both, in vitro and in vivo. Thus, a simple and inexpensive UV–Vis spectrophotometric method is proposed to directly determine acetone from nanoparticles suspensions employing its reaction with vanillin. Central composite designs were employed to correct and optimize the quantification method, which was then validated according to international guidelines. The optimized method resulted accurate, precise, and linear in the range of 10–50 µg/mL, with an R2 of 0.998 and limits of detection and quantification of 2.6 and 7.8 µg/mL, respectively. The effect of several surfactants employed during nanoparticles preparation was not detrimental to the method. The proposed procedure can be successfully applied to directly quantify acetone from nanoparticles suspensions.

Original languageEnglish
Pages (from-to)751-760
Number of pages10
JournalPharmaceutical Development and Technology
Volume24
Issue number6
DOIs
StatePublished - 3 Jul 2019
Externally publishedYes

Keywords

  • Drug delivery systems
  • UV-Vis spectroscopy
  • acetone
  • central composite design
  • residual solvents

Fingerprint

Dive into the research topics of 'UV–Vis spectroscopic quantification of residual acetone during the development of nanoparticulate drug delivery systems'. Together they form a unique fingerprint.

Cite this